Expensive specialty drugs are a growing concern that are traditionally overlooked in drug diversion efforts.
Michael Sovie, Executive Vice President of Sales
Advertisement
Articles by Michael Sovie, Executive Vice President of Sales
Advertisement
Latest Updated Articles
- Mitigating Drug Diversion Risk: More Than Just Narcotics, Specialty Needs to Look at This Growing Problem
Published: March 15th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes
5
